Home > Annual Financials > TTK HEALTHCARE

TTK HEALTHCARE Financial Statement Analysis
[BOM: 507747|NSE : TTKHLTCARE]

The Revenues of TTK HEALTHCARE have increased by 21.00% YoY .
The Earnings Per Share (EPS) of TTK HEALTHCARE has increased by 141.30 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

TTK HEALTHCARE Last 5 Annual Financial Results
[BOM: 507747|NSE : TTKHLTCARE]

StandaloneMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹725 Cr₹599 Cr₹476 Cr₹646 Cr₹628 Cr
Expenses ₹694 Cr₹577 Cr₹457 Cr₹617 Cr₹578 Cr
Operating Profit (Excl OI) ₹31 Cr₹22 Cr₹19 Cr₹28 Cr₹50 Cr
Other Income ₹48 Cr₹16 Cr₹9.94 Cr₹8.78 Cr₹7.75 Cr
Interest ₹5.24 Cr₹3.24 Cr₹1.71 Cr₹3.27 Cr₹3.38 Cr
Depreciation ₹13 Cr₹13 Cr₹13 Cr₹14 Cr₹15 Cr
Profit Before Tax ₹62 Cr₹25 Cr₹23 Cr₹19 Cr₹39 Cr
Profit After Tax ₹45 Cr₹19 Cr₹37 Cr₹12 Cr₹24 Cr
Consolidated Net Profit ₹640 Cr₹42 Cr₹46 Cr₹12 Cr₹24 Cr
Earnings Per Share (Rs)₹31.61₹13.10₹26.03₹8.72₹17.25
PAT Margin (%)6.163.097.731.913.88
ROE(%)7.016.0213.765.0110.25
ROCE(%)10.138.598.388.2815.46
Total Debt/Equity(x)0.030.060.060.120.12

Key Financials

Market Cap : ₹ 2,059.5 Cr
Revenue (TTM) : ₹ 751.9 Cr
Net Profit(TTM) : ₹ 65.0 Cr
EPS (TTM) : ₹ 46.1
P/E (TTM) : 31.7

Industry Peers & Returns1W1M1Y
TTK HEALTHCARE -6.5% -8.3% 18.2%
SUN PHARMACEUTICAL INDUSTRIES 0.9% -6.6% 58.8%
CIPLA -1% -5.6% 54.6%
DR REDDYS LABORATORIES 0.9% 2.2% 27.3%
ZYDUS LIFESCIENCES 2.8% -0.6% 96.2%
DIVIS LABORATORIES -2.2% 6.2% 21.2%
MANKIND PHARMA -6.3% -5% NA
TORRENT PHARMACEUTICALS -0.9% 1.1% 64.2%
LUPIN -2.1% 0.4% 137.2%


TTK HEALTHCARE Revenues
[BOM: 507747|NSE : TTKHLTCARE]

Y-o-Y

21.00 %

5 Yr CAGR

3.66 %

Years Revenues % Change
Mar2023 ₹725 Cr
21.00
Mar2022 ₹599 Cr
25.88
Mar2021 ₹476 Cr
-26.28
Mar2020 ₹646 Cr
2.85
Mar2019 ₹628 Cr -


TTK HEALTHCARE Operating Profit
[BOM: 507747|NSE : TTKHLTCARE]

Y-o-Y

43.56 %

5 Yr CAGR

-10.82 %

Years Operating Profit % Change
Mar2023 ₹31 Cr
43.56
Mar2022 ₹22 Cr
13.03
Mar2021 ₹19 Cr
-31.72
Mar2020 ₹28 Cr
-42.90
Mar2019 ₹50 Cr -

Operating Margins
Y-o-Y

18.68 %

5 Yr CAGR

-13.98 %

Years Operating Margin% % Change
Mar2023 4.32%
18.68
Mar2022 3.64%
-10.34
Mar2021 4.06%
-7.31
Mar2020 4.38%
-44.49
Mar2019 7.89% -

TTK HEALTHCARE Profit After Tax
[BOM: 507747|NSE : TTKHLTCARE]

Y-o-Y

1,438.22 %

5 Yr CAGR

126.34 %

Years Profit After Tax % Change
Mar2023 ₹640 Cr
1,438.22
Mar2022 ₹42 Cr
-10.45
Mar2021 ₹46 Cr
276.99
Mar2020 ₹12 Cr
-49.46
Mar2019 ₹24 Cr -

PAT Margins
Y-o-Y

99.35 %

5 Yr CAGR

12.25 %

Years PAT Margin(%) % Change
Mar2023 6.16 %
99.35
Mar2022 3.09 %
-60.03
Mar2021 7.73 %
304.71
Mar2020 1.91 %
-50.77
Mar2019 3.88 % -

TTK HEALTHCARE Earnings Per Share (EPS)
[BOM: 507747|NSE : TTKHLTCARE]

Y-o-Y

141.30 %

5 Yr CAGR

16.35 %

Years EPS % Change
Mar2023 ₹32
141.30
Mar2022 ₹13
-49.67
Mar2021 ₹26
198.51
Mar2020 ₹8.72
-49.45
Mar2019 ₹17 -

TTK HEALTHCARE Return on Capital Employed (ROCE)
[BOM: 507747|NSE : TTKHLTCARE]

Y-o-Y

17.93 %

5 Yr CAGR

-10.03 %

Years ROCE % Change
Mar2023 10.13%
17.93
Mar2022 8.59%
2.51
Mar2021 8.38%
1.21
Mar2020 8.28%
-46.44
Mar2019 15.46% -

TTK HEALTHCARE Share Price vs Sensex

Current Share Price : ₹1,460.7
Current MarketCap: ₹ 2,059.5 Cr
Updated EOD on :May 07,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

-6.5%

-8.3%

18.2%

SENSEX

-1.6%

-0.5%

19.8%

TTK HEALTHCARE related INDICES

BSE Indices1W1M1Y
S&P BSE ALLCAP -1.8% 0.4% 35.7%
S&P BSE MIDSMALLCAP -2.3% 2% 59%
S&P BSE INDUSTRIALS -2.4% 1.7% 74.8%
S&P BSE SMALL CAP -2.9% 2% 57.8%
No NSE index found

You may also like the below Video Courses


FAQ about TTK HEALTHCARE Financials


How the annual revenues of TTK HEALTHCARE have changed ?

The Revenues of TTK HEALTHCARE have increased by 21.00% YoY .

How the Earnings per Share (EPS) of TTK HEALTHCARE have changed?

The Earnings Per Share (EPS) of TTK HEALTHCARE has increased by 141.30 % YoY .